The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

The company agreed to pay $138.75 million to resolve a class-action lawsuit that alleged the company concealed problems during the expansion of a giant copper mine in Mongolia.

By Rhiannon Hoyle Rio Tinto agreed to pay $138.75 million to resolve a class-action lawsuit that alleged the company concealed problems during the expansion of a giant copper mine in Mongolia.

The article and its headline were updated on June 18 to include LAUSD’s previously undisclosed information revising total costs of the bonds it authorized to settle sexual abuse claims against it.

Shaquille O’Neal, the retired basketball star, agreed to pay $1.8 million to settle a class-action suit brought by customers of FTX, the collapsed cryptocurrency exchange, accusing him and other ...

GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults below the age of 50 who are at risk of the disease, the British drugmaker ...

Phase 1 and interim phase 2 data met GSK’s immunogenicity success criteria, the London-based drugmaker said. Yet, GSK has decided to hand off to India’s Bharat for the phase 3 trial.

Rio Tinto Agrees to Pay Nearly $139 Million to Settle Mongolia Copper Mine Lawsuit — Update Provided by Dow Jones Jun 18, 2025, 9:52:00 PM ...

President Trump’s legal battles and threats of future litigation for allegedly defamatory coverage are forcing news outlets to make tough decisions about whether to fight them or pay multi-million ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious disease R&D for the British pharma. | After nearly 25 years with Sanofi ...